Lansoprazole
Overview
Lansoprazole is a proton pump inhibitor which reduces stomach acid production. It is used primarily in the treatment of gastric ulcers and gastroesophageal reflux disease (GERD).
API suppliers (33)
Suppliers of Lansoprazole evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 28 of 33 suppliers.
16 of 33 hold a GMP certificate on record in the EU or UK registers · 1 holds a European CEP for this substance
- LEE PHARMA LTDIndia1 active DMF GMP on record
- UNION QUIMICO FARMACEUTICA SA (UQUIFA SA)Spain1 active DMF
- MOEHS IBERICA SLSpain1 active DMF GMP on record
- Zydus Lifesciences LimitedIndia1 active DMF GMP on record
- Wockhardt UsaUnited Kingdom1 active DMF
- Hetero Drugs LimitedIndia1 active DMF GMP on record
- JUBILANT PHARMOVA LTDIndia1 active DMF
- Sun Pharmaceutical Industries LimitedIndia1 active DMF GMP on record
- Natco Pharma Usa1 active DMF
- ULKAR KIMYA SANAYII VE TICARET AS1 active DMF
- QUIMICA SINTETICA SASpain1 active DMF GMP on record
- Alkem Laboratories LimitedIndia1 active DMF GMP on record
- SHOUGUANG FUKANG PHARMACEUTICAL CO LTDChina1 active DMF GMP on record
- CHROMO LABORATORIES INDIA PRIVATE LTDIndia1 active DMF
- METROCHEM API PRIVATE LTDIndia1 active DMF
- MSN Organics Private LimitedIndia1 active DMF
- Macleods Pharmaceuticals Ltd.India1 active DMF GMP on record
- TAPI NL BVNetherlands1 active DMF
- MATRIX PHARMACORP PRIVATE LTDIndia1 active DMF
- Cipla LimitedIndiaCEP GMP on record
- Apotex Pharmachem India Pvt. Ltd.India
- ITF CHEMICAL LTDABrazil
- FLAMMA SPAItaly GMP on record
- ESTEVE QUIMICA SA GMP on record
- SYN-TECH CHEM AND PHARM CO LTDTaiwan
Showing 25 of 33 suppliers — see the full list in the app.
EU CEP holders (16)
Companies holding a valid EU Certificate of Suitability (CEP) for Lansoprazole, from the EDQM certification database. A CEP holder is a documented EU-market source of the substance — not necessarily the manufacturer — and these are not yet profiled in our directory.
Patent & exclusivity (US)
Per the FDA Orange Book (41 approved US products), the latest listed US patent on Lansoprazole expires 21 Apr 2036. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- 2-[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methylsulfinyl]-1H-benzimidazole
- Canonical SMILES
- CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F
- InChIKey
- MJIHNNLFOKEZEW-UHFFFAOYSA-N
Therapeutic areas
Do you supply Lansoprazole? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.